4 employees
Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.
2018
$16M
from 1 investors over 1 rounds
Appello Pharmaceuticals, Inc. raised $16M on June 28, 2018
Investors: Mountain Group Partners